On Thursday, the Centers for Disease Control and Prevention Advisory Group endorsed Pfizer's (PFE) - Get Free Report COVID-19 booster shots for individuals 65 and older and also for those who have a high risk of severe COVID-19.
CDC endorsed Pfizer's booster shot one day after the Food and Drug Administration (FDA) approved it for the emergency authorization for individuals ages 65 and older as well as vulnerable populations.
“Today’s action demonstrates that science and the currently available data continue to guide the FDA’s decision-making for COVID-19 vaccines during this pandemic. After considering the totality of the available scientific evidence and the deliberations of our advisory committee of independent, external experts, the FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to allow for a booster dose in certain populations such as health care workers, teachers, and daycare staff, grocery workers and those in homeless shelters or prisons, among others,” said Acting FDA Commissioner Janet Woodcock. “This pandemic is dynamic and evolving, with new data about vaccine safety and effectiveness becoming available every day. As we learn more about the safety and effectiveness of COVID-19 vaccines, including the use of a booster dose, we will continue to evaluate the rapidly changing science and keep the public informed.”
The decision, which will need to be followed up by similar approval from the Centers for Disease Control and Prevention, could pave the way for both a specific booster shot campaign in the coming weeks and a broader program during the winter months if similar permissions are granted to vaccine makers like Moderna (MRNA) - Get Free Report and Johnson & Johnson (JNJ) - Get Free Report," writes TheStreet Martin Baccardax.
Earlier this month, on Sept. 17, the FDA rejected the approval of Pfizer booster shots for all adults.
The Pfizer-BioNTech vaccine is the first and only fully FDA-approved COVID-19 vaccine.